On-Demand Videos

An expert exchange with Dr. Rena Callahan* (UCLA) and Dr. Vijay Paryani* (Duke Health) focused on: Navigating evolving genomic testing options to help inform treatment recommendations Integrating recent-meta-analysis results into individualized patient care Translating data into personalized clinical decisions through patient case reviews *Speakers listed are consultants of Biotheranostics, Inc. Statements reflect the speakers’ own personal views and interpretations.

Linda Moors, PA-C* partnered with her patient Cheryl to make important decisions regarding her breast cancer treatment. When it came to making a decision about extended endocrine therapy, they both knew the Breast Cancer Index® Test would help give Cheryl the personalized answers she wanted. *Linda Moors, PA-C is a consultant of Biotheranostics, Inc. Statements reflect the speakers’ own personal views and interpretations.

A case-based program on the management of patients with early-stage, HR+ breast cancer. Rena Callahan, MD* and Katherine Cohen, NP* from University of California, Los Angeles review recently published data and guidelines for extended endocrine therapy, discuss collaboration between Medical Oncologists and Advanced Practice Providers in the management of breast cancer survivors and discuss real-world cases with a focus on avoiding over- and under- treatment. *Speakers listed are consultants of Biotheranostics, Inc. Statements reflect the speakers' own personal views and interpretations.

Watch Drs. Rena Callahan*, UCLA Health, and VK Gadi*, University of Illinois Cancer Center, discuss evolving trends in early-stage, HR+ breast cancer diagnostics. Listen to them present the data on the Breast Cancer Index® Test and discuss utilization of the test in clinical case studies. *Speakers listed are consultants for Biotheranostics, Inc. Statements reflect the speakers’ own personal views and interpretations.